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Objective: To explore potential relationships between sperm DNA integrity and both semen parameters and clinical outcomes. 
Methods: Semen analysis of 498 samples was performed according to the 2010 criteria of the World Health Organization. The sperm DNA frag-
mentation Index (DFI) of the semen samples was assessed using a neutral comet assay. 
Results: Sperm DFI showed a significant correlation with semen parameters, including the patient’s age, sperm viability, motility, morphology, 
and number of leukocytes (p<0.05). The sperm DFI values for asthenozoospermic (15.2%), oligoteratozoospermic (18.3%), asthenoteratozoo-
spermic (17.5%), and oligoasthenoteratozoospermic semen samples (21.3%) were significantly higher than that observed in normozoospermic 
semen samples (10.5%, p<0.05). A sperm DFI value of 14% was used as a threshold of sperm DFI in assessing whether DNA was highly dam-
aged. In 114 IVF-ET cycles, the fertilization rate of the sperm DFI <14% group (70 cycles, 61.7%) was significantly higher than that observed for 
the ≥14% group (44 cycles, 55.3%), but there was no difference in the other clinical outcomes between the two groups. In the ≥14% group, 
the pregnancy rates of the ICSI cycles (40.0%) and half-ICSI (44.0%) were higher than conventional IVF cycles (30.7%), but the difference was 
not statistically significant. 
Conclusion: Along with the conventional semen analysis, the sperm DFI assessed using the comet assay was shown to improve the quality of 
the semen evaluation. To evaluate the precise effect of ICSI on pregnancy rates in the patients who demonstrate high sperm DFI values, further 
study is necessary.
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Introduction
Traditionally, the diagnosis of male infertility is based on micro-
scopic assessment, including the concentration, motility, and mor-
phology of sperm, but the results of this conventional semen analysis 
are insufficient as a diagnostic tool in male infertility. Recently, sperm 
DNA integrity has been regarded as a complementary diagnostic 
tool and biologic marker of male reproductive health and infertility. 
It is well known that DNA damage in spermatozoa occurs during 
late spermatogenesis as a consequence of endogenous factors pres-
ent in the testis/epididymis, or due to exogenous factors present af-
ter ejaculation. Potential mechanisms for generating DNA damage in 
sperm have been proposed, and include incomplete chromatin pack-
aging [1], abortive apoptosis [2], oxidative stress by reactive oxygen 
species (ROS) [3], and an imbalance in endogenous hormone levels 
[4]. Unlike other cells, spermatozoa are more vulnerable to DNA dam-
age because they do not have the capacity for DNA repair. Therefore, 
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if sperm with damaged DNA are able to successfully fertilize an oo-
cyte, it may result in pathologies such as infertility [3], childhood can-
cer [5], and imprinting diseases [6,7]. During fertilization, the oolem-
ma acts as a selective barrier and prevents the penetration of anoma-
lous spermatozoa. In ICSI cycles, the sperm selection mechanism of 
the oocytes is bypassed, which may increase the risk of transmitting 
damaged DNA. However, there is some debate on the actual risk of 
ICSI in regard to the selective barrier of the oolemma for the sperm 
with damaged DNA. 
The most widely used methods to detect DNA integrity in individu-
al spermatozoa are the sperm chromatin structure assay (SCSA) [8,9], 
the terminal deoxynucleotidyl transferase-mediated dUDP nick-end 
labeling (TUNEL) assay [10-12], and the alkaline [13,14] and neutral 
comet assay [15-17].  Each of these tests determines different aspects 
of DNA damage. The SCSA and TUNEL assays require the use of ex-
pensive instrumentation, such as flow-cytometry equipment for pre-
cise assessment. Alternatively, the neutral comet assay is technically 
simpler to use, is more cost efficient, and has a comparably higher 
sensitivity for detecting DNA damage. Thus, the latter technique may 
be more suitable for routine measurements involving the quantifica-
tion of double-strand (ds) break DNA damage in sperm cells [17].  
A number of studies have shown a relationship between human 
sperm DNA damage and various semen parameters including sperm 
concentration, motility, morphology, and leukocyte concentration 
[18-23]. Sperm DNA damage has also demonstrated a negative ef-
fect on the mitochondrial activity of sperm [22,24], the efficiency of 
fertilization [25-27], embryo development [25,28,29], the chances of 
a successful pregnancy [26,29-31], and the ability to bring the preg-
nancy to term [32,33]. Interestingly, a patient’s age [17,25] and en-
dogenous hormone level [34] were associated with the integrity of 
sperm DNA. In contrast, other research groups did not observe a 
close relationship between sperm DNA integrity and sperm mor-
phology [35], fertilization rate, embryo development [36], or preg-
nancy outcome for ICSI [10]. The analysis of the sperm DNA integrity 
is important for improving the accuracy of semen analysis and the 
diagnosis of male infertility. However, various threshold values of 
sperm DNA integrity have been reported and differ due to both the 
variety of methods employed and the inherent variations in results 
among different research laboratories. Moreover, there is debate re-
garding the relationship between the sperm DNA integrity and the 
clinical outcome. 
Here we have used a modified neutral comet assay to provide 
quantitative measurements of DNA damage in human sperm using 
a large sample size to more accurately approximate the optimal 
threshold value of sperm DNA integrity. We also explored the rela-
tionships among the sperm DNA integrity, semen parameters, and 
the clinical outcome in IVF programs. 
Methods
This study was approved by our Institutional Review Board (the 
Mizmedi Hospital Research Ethics Committee).
1.	Semen	samples
A total of 498 semen samples were analyzed using the comet assay 
after undergoing a freeze-thaw cycle. The comet assay technique 
was performed on 114 semen samples obtained from male patients 
who were subjected to the IVF-ET program. The samples were used 
to ascertain the presence of a possible relationship between the 
sperm DNA integrity and clinical outcome in the IVF-ET program. 
2.	Semen	analysis
Semen samples were obtained via masturbation after two to five 
days of ejaculatory abstinence and were analyzed within one hour of 
collection. After seminal liquefaction, a routine semen analysis was 
performed using computer-aided semen analysis (CASA; Medical 
Supply, Seoul, Korea) according to the 2010 World Health Organiza-
tion (WHO) specifications. The semen samples with a concentration 
≥15×10
6 sperm/mL, a motility ≥40%, a viability ≥58%, a normal 
morphology ≥4%, and leucocytes <1×10
6 cells/mL were consid-
ered parameters that characterize normal semen samples. A specific 
nomenclature is used by andrologists to describe abnormal semen 
samples encountered during semen analysis. In the present study, 
abnormal semen samples were characterized by the nomenclature 
according to the 2010 WHO criteria. An oligozoospermic semen sam-
ple means a reduced sperm concentration of <15×10
6 sperm/mL, 
an asthenozoospermic semen sample means a decreased sperm 
motility <40%, and a teratozoospermic semen sample means a de-
creased number of spermatozoa with normal morphology <4%. 
When a semen sample shows abnormal sperm concentration, motil-
ity, and morphology, we use combinations of these terms, such as 
“oligoasthenoteratozoospermic” semen sample.
3.	Freeze-thaw	cycle	of	semen	samples	
The semen samples were collected and cryopreserved in a quantity 
suitable for three days worth of analysis because the comet assay 
was performed twice in one week in the interest of efficiency. The se-
men samples were frozen using ultra-rapid freezing in the absence of 
a cryopreservative to minimize the cryodamage to the sperm DNA as 
described previously [15]. The entire semen sample was placed into 
cryovials and was frozen by static-phase vapor cooling (10 cm above 
the level of liquid nitrogen [LN2]; -80°C) for 10 minutes. The samples 
were then submerged into LN2 (-196°C) and stored until needed. Pri-
or to experimentation, the samples were removed from LN2 and the 
cryovials were left at room temperature for 1 minute before being   doi: 10.5653/cerm.2011.38.1.10
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submerged into a 37°C water bath. Once the samples were com-
pletely thawed, an equal volume of Ca
2+ and Mg
2+- free phosphate 
buffered saline (PBS) was mixed with the sample and centrifuged at 
300 g for 5 minutes to remove seminal plasma and small particles. In 
the preliminary test, there was no significant difference in the sperm 
DNA integrity between the fresh semen samples and the freeze-
thawed semen samples assessed using the comet assay.
4.	Comet	assay
The sperm DNA integrity was assessed using the modified neutral 
comet assay as described previously [37]. Comet assay was perfor-
med using a comet assay kit (Trevigen, Gaithersburg, MD, USA). A 
mixture of semen (5 μL) and low melting agarose (45 μL) was layered 
onto a comet slide. The slide was transferred to a 4°C refrigerator for 
10 minutes. The slide was then submerged into a pre-cooled lysing 
solution (containing 2.5 M NaCl, 100 mM EDTA, 10 mM Tris, 1% Triton 
X-100, and 10 mM DL-Dithiothreitol; Sigma, St. Louis, MO, USA) for 2 
hours prior to being placed in an electrophoresis buffer (500 mM 
NaCl, 100 mM Tris, 1 mM EDTA, and 0.2% DMSO; Sigma) for 20 min-
utes. After electrophoresis for 60 minutes at 10 V and 250 mA, the 
slide was washed with PBS and a neutralizing solution (50% Ethanol, 
20 mM Tris, and 1 mg/mL Spermine; Sigma). After washing with PBS, 
the slide was stained with SYBR staining solution containing 10 mM 
Tris, 1 mM EDTA, and 0.01% SYBR Green (Trevigen). Images (400× 
magnification) were captured using a digital camera imaging system 
(Nikon digital sight DS-U1) attached to a fluorescence-inverted mi-
croscope (Figure 1).
5.	IVF-ET	program
Ovulation induction was achieved after several days of GnRH ago-
nist suppression and was initiated through the administration of re-
combinant follicle stimulating hormone for a period of 9 to 12 days, 
followed by 10,000 U of hCG generally administered on the 10th day, 
when the largest follicular diameter was approximately 18 mm. Un-
like the Comet assay, fresh semen was used for the IVF-ET program 
and motile sperm was prepared using a density gradient. The sperm 
washing buffer, fertilization medium, and embryo culture medium 
used for all protocols were GIII series medium (Vitrolife, Göteborg, 
Sweden). The embryo transfer step was performed on day three and 
the clinical pregnancy status was confirmed by observation of the 
uterine sac with a beating heart using ultrasonographic detection. A 
total of 114 IVF-ET cycles (36 conventional IVF cycles, 23 half-ICSI cy-
cles, and 55 ICSI cycles) were involved in the present study. ICSI was 
used for the patients who showing male factors, a low number of 
mature eggs, or a low fertilization rate in the previous conventional 
IVF cycle. Half-ICSI was used for the patients who underwent the first 
conventional IVF cycle to prevent the total failure of fertilization. The 
IVF-ET cycles were divided into two groups according to the threshold 
of the sperm DNA integrity: 1) the <14% group and 2) ≥14% group. 
6.	Statistical	analysis
The association between the sperm DFI and the semen parameters 
was explored using Pearson’s correlation and a two-tailed Student’s 
t-test. These statistical procedures were performed using the SPSS 
ver. 16.0 (SPSS Inc., Chicago, IL, USA). The clinical outcomes between 
the experiment and control groups were analyzed using the chi-squ-
are test; a p-value <0.05 was considered statistically significant.
Results
1.	Correlation	between	sperm	DFI	and	semen	parameters	
A correlation between sperm DFI and semen parameters was inves-
tigated in the 498 semen samples (Figure 2). The degree of correlation 
was assessed with the correlation coefficient (r) and p-value. Sperm 
DFI decreased significantly when the sperm viability (r=-0.605, 
p<0.001), motility (r=-0.395, p<0.001), rapid motility (r=-0.216, 
p<0.001) or morphology (r=-0.219, p<0.01) increased, but sperm 
DFI increased as the patient’s age (r= 0.134, p<0.01) or leukocyte 
concentration in the semen increased (r=0.138, p<0.01). However 
there was no significant correlation between sperm DFI and sperm 
count (r=0.004, p=0.91) or semen volume (r=0.028, p=0.53).
2.	Sperm	DFI	of	subfertile	semen	samples	
The sperm DFI of subfertile semen samples was compared with 
that of normal semen samples (Figure 3). The sperm DFI in astheno-
zoospermic (15.2±9.5%), oligoteratozoospermic (18.3±12.2%), as-
thenoteratozoospermic (17.5±13.4%), and oligoasthenoteratozoo-
spermic semen samples (21.3±11.2%) were significantly higher 
Figure	1. Procedure of neutral comet assay. LMAgarose, low melting 
agarose.
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Figure	2. Correlation between semen parameters and sperm DNA fragmentation index (DFI) assessed using neutral comet assay in 498 semen 
samples. p<0.05 was considered statistically significant, r=coefficient. NS, not significant. 
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than the percentage in normozoospermic semen samples (10.5± 
7.1%, p<0.05). 
3.	Threshold	of	sperm	DFI
On the basis of the potential correlation of sperm DNA integrity with 
semen analysis, we used a DFI of 14% as a threshold of the sperm DFI 
in assessing whether DNA was highly damaged. When the 498 semen 
samples were divided into two groups (<14% and ≥14% groups) 
according to the threshold value of DFI (14%), the mean values of all 
the semen parameters in the <14% group were significantly higher 
than those of the ≥14% group (p<0.05), with the exception of the 
sperm count (Table 1). 
4.	Association	between	sperm	DFI	and	clinical	outcome	in	IVF-
ET	cycles
Unlike with semen parameters, the sperm DNA integrity did not 
demonstrate a close correlation with the clinical outcome in 114 IVF-
ET cycles (Table 2). The fertilization rate (61.7%) of the sperm DFI 
<14% group was significantly higher than the rate of the ≥14% 
group (55.3%, p<0.05). However, there were no differences in the 
percentage of good embryos and the pregnancy rate between the 
<14% group (32.2% and 35.7%) and the ≥14% group (33.6% and 
38.6%). The abortion rate in the <14% group (5.7%) was lower com-
pared to the ≥14% group (11.3%), but a statistically significant dif-
ference was not observed due to the small number of IVF-ET cycles. 
5.	Association	between	sperm	DFI	and	conventional	IVF	and	
ICSI	cycles	
Of the 114 IVF-ET cycles, 36 conventional IVF cycles, 23 half-ICSI cy-
cles and 55 ICSI cycles were performed according to the semen quali-
Table	1. Characteristics of 498 semen samples divided by the thresh-
old value (14%) of sperm DFI
Semen
parameters
Characteristics of semen samples
p-value Sperm DFI 
<14% group
Sperm DFI
≥14% group
Age (yr) 34.7±3.9 36.0±4.6 <0.001
Count (x10
6/mL) 62.5±44.8 58.0±49.1 0.147
Motility (%) 44.2±18.5 31.1±19.2 <0.001
Viability (%) 88.6±7.6 76.7±18.7 <0.001
Morphology (%) 5.26±3.1 4.36±2.6 <0.001
Leukocyte (x10
6/mL) 1.93±6.2   2.64±6.2 0.010
Values are presented as mean±SD.
p<0.05 was considered statistically significant.
DFI, DNA fragmentation index.
Table	2. Association between the sperm DFI and clinical outcomes 
in 114 IVF-ET cycles
Characteristics of IVF-ET cycles Sperm DFI 
<14% group
Sperm DFI 
≥14% group p-value
No. of IVF-ET cycles 70 44
Age of male 35.4±3.9 38.0±5.8 0.005
Age of female 33.3±3.8 35.5±3.9 0.004
No. of egg retrieved 8.9±5.5 9.2±5.7 0.770
Endometrial thickness (mm) 10.4±1.4 10.1±1.6 0.330
No. of embryos transferred 2.48±0.7 2.50±0.9 0.920
No. of fertilized/oocytes 388/628 (61.7) 226/408 (55.3) 0.040
No. of good embryos 125/388 (32.2) 76/226 (33.6) 0.780
No. of pregnancy cycles 25/70 (35.7)  17/44 (38.6) 0.900
No. of implanted/transferred  28/174 (16.1) 22/110 (20.0)  0.490
No. of abortion cycles 4/70 (5.7) 5/44 (11.3) 0.460
Values are presented as mean±SD, or number (%).
p<0.05 was considered statistically significant.
IVF-ET, in vitro fertilization-embryo transfer; DFI, DNA fragmentation index. 
Figure	4. Association between the sperm DFI and conventional IVF 
and ICSI cycles. There was no significant difference in the pregnancy 
rates between the two groups. DFI, DNA fragmentation index; IVF, in 
vitro fertilization; ICSI, intracytoplasmic sperm injection.
 Conventional IVF cycles         Half-ICSI cycles                        ICSI cycles
45
40
35
30
25
20
15
10
5
0
P
r
e
g
n
a
n
c
y
 
r
a
t
e
 
(
%
)
Sperm DFI<14% group Sperm DFI≥14% group
30.7 30.4
7/23 
cycles
4/13 
cycles
6/16 
cycles
3/7 
cycles
12/31 
cycles
10/24 
cycles
37.5
42.8
38.7
41.6
Figure	3. Comparison of sperm DNA fragmentation index (DFI) be-
tween subfertile semen samples and normal semen samples. 
aThe 
values (DFI) of subfertile semen samples were significantly higher than 
the value of normozoospermic samples. Values are presented as mean 
±SD. p<0.05 was considered statistically significant. N, normozoo-
spermic; O, oligozoospermic; A, asthenozoospermic; T, teratozoosper-
mic; OA, oligoasthenozoospermic; OT, oligoteratozoospermic;  AT, as-
thenoteratozoospermic; OAT, oligoasthenoteratozoospermic. 
  N  O  A  T  OA  OT  AT  OAT
10.5±7.1 9.2±4.5
15.2±9.5a
11.9±7.0
14.0±6.4
18.3±12.2a
17.5±13.4a
21.3±11.2a 25
20
15
10
5
0
Sperm DFI 
Semen sampleswww.eCERM.org
HJ Chi et al.     Integrity of human sperm DNA assessed by the neutral comet assay
15
ty, oocyte maturity, and previous IVF outcome of the patients (Figure 
4). In the sperm DFI <14% group, the pregnancy rates of the ICSI, the 
half-ICSI, and the conventional IVF cycles were 40.0%, 35.7%, and 
30.4%, respectively, whereas the pregnancy rates of the ≥14% group 
were 40.0%, 44.4%, and 30.7%, respectively. There was no significant 
difference in the pregnancy rates between the two groups due to the 
small number of the IVF-ET cycles. 
Discussion
Although many methodologies are available to assess DNA frag-
mentation in spermatozoa, we conclude that the neutral comet as-
say is a technically simple and cost-efficient method to measure the 
ds DNA breaks in sperm cells [17]. The neutral comet assay seems to 
be more sensitive to and reliable for the detection of ds DNA breaks 
than the alkaline comet assay because the alkaline conditions inher-
ently induce the formation of DNA damage, a phenomenon that is 
not observed with the neutral comet assay [38]. 
In the present study, we had to freeze the semen samples for the 
comet assay because the comet assay was performed only twice a 
week. The semen samples were frozen using an ultra-rapid freezing 
method in the absence of a cryopreservative to minimize the cryo-
damage to the sperm DNA integrity as described previously by Duty 
et al [15]. They reported that flash-freezing in LN2 in the absence of a 
cryoprotectant most closely reproduced the results obtained using 
fresh semen samples. In our preliminary test, there was also no differ-
ence in the sperm DNA integrity between the fresh and the freeze-
thawed semen samples assessed using the comet assay. This result is 
supported by the observation that DNA of the spermatozoa obtained 
from fertile men was found to be unaffected by the cryopreservation 
process [21]. 
In the present study, the sperm DFI was significantly increased in 
the subfertile semen samples compared to normal semen samples 
(Figure 3). Shamsi et al. [23] reported a similar statistically significant 
increase in DNA damage in oligozoospermic (20%), asthenozoosper-
mic (24%), teratozoospermic (28%), and oligoasthenoteratozoosper-
mic (OAT) semen samples (43%) when compared to control samples 
(8%). In addition, other authors reported that oligozoospermic [28], 
teratozoospermic [39], leukocytospermic [22], and OAT semen sam-
ples [14] showed a significant increase in the amount of DNA dam-
aged sperm. 
Various threshold values of sperm DFI have been proposed accord-
ing to the various protocols and criteria used to determine them. The 
SCSA method has defined a 27% to 30% DFI as the point at which an 
individual is placed into the sub-fertile group [40], and the neutral 
comet assay method has suggested that ds DNA breaks are present 
in 15% to 25% of native sperm [16]. It is certainly reasonable that the 
threshold value of the sperm DNA integrity will be adjusted by ongo-
ing studies. In the present study, the mean value of sperm DNA in-
tegrity in 498 semen samples was 14.1%, and 14% as a cutoff value 
of sperm DFI showed a significantly closer relationship between the 
sperm DFI and various semen parameters compared to any other 
cutoff values. Thus we decided to use 14% as a threshold of sperm 
DFI to assess whether DNA was highly damaged. Moreover, a previ-
ous study of the sperm chromatin dispersion test used 15% as the 
threshold of fertile sperm DFI [41], which supports our decision to 
use a threshold of 14%. The 498 semen samples were divided by the 
threshold into two groups (a <14% group and a ≥14% group). We 
observed that age correlates with an increase in the percentage of 
sperm with highly damaged DNA, as indicated in previous reports 
[17,19,25]. The mean values of sperm motility, morphology, and via-
bility in the <14% group were significantly higher than the values in 
the ≥14% group. These observations were similar to the reports that 
lower levels of semen quality are characterized by higher levels of 
DNA damage [10,39].
Extensive sperm nuclear DNA fragmentation has been positively 
correlated with lower fertilization rates [41], poorer embryo develop-
ment [25], lower pregnancy rates and an increased incidence of 
spontaneous abortion [31,34]. In contrast, some authors reported 
that there was no correlation between sperm DNA integrity and the 
clinical outcomes in ICSI cycles [1,10,36]. In the present study, we di-
vided 114 IVF-ET cycles into the <14% (70 cycles) and the ≥14% 
group (44 cycles) based on the sperm DFI threshold value. Although 
the fertilization rate of the <14% group was significantly higher 
than the rate of the ≥14% group, there were no differences in the 
other clinical outcomes between the two groups (Table 2). The com-
parison of the clinical outcomes between the two groups may be an 
incomplete analysis because the IVF-ET cycles were divided into two 
groups by the threshold value that was only based on the semen pa-
rameters. Moreover, we could not perform a proper statistical com-
parison due to the small number of IVF-ET cycles. Therefore, many 
additional IVF-ET cycles are needed to more thoroughly explore the 
relationship between sperm DNA integrity and the clinical outcome, 
with a threshold based on the clinical criteria.
In ICSI cycles, the sperm with damaged DNA can be used for fertil-
ization by bypassing the sperm selection mechanism of the oocytes. 
Nevertheless there was no correlation between the sperm DFI and 
the ICSI outcomes [1,10,36]. Furthermore, it was suggested that ICSI 
might help overcome the diminished pregnancy prognosis with high 
sperm DFI [40]. In the present study, although there was no statistical 
significance, the pregnancy rates of ICSI cycles were higher than con-
ventional IVF cycles (Figure 4). This result suggests the possibility that 
ICSI may be better than conventional IVF for maintaining a stable 
pregnancy rate even in the high sperm DFI group. ICSI may be a bet-  doi: 10.5653/cerm.2011.38.1.10
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ter method to exclude sperm with high DFI values because most 
embryologists strive to select only those sperm showing sufficient 
motility and normal morphology for injection. As mentioned above, 
these semen parameters demonstrated a close relationship with the 
sperm DNA integrity. In conclusion, we confirmed that the modified 
neutral comet assay is a simple, valuable, and reliable method for as-
sessing sperm DNA integrity. Sperm DNA integrity was correlated 
with semen parameters and 14% was the optimal threshold of the 
sperm DFI on the basis of these aforementioned characteristics, at 
least in this study. Therefore, sperm DNA integrity may be a good 
biomarker to evaluate semen quality and to diagnose male infertility 
in conjunction with semen analysis. Although we observed a rela-
tionship between sperm DNA integrity and the fertilization rate in 
the IVF-ET cycles, we did not observe a relationship with other clini-
cal outcomes. Further studies on the relationship between sperm 
DNA integrity and clinical outcome are necessary.
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